NCT02735369: A Study Assessing Efficacy and Safety of OC-10X in the Treatment of PDR |
|
|
| Terminated | 2 | 40 | RoW | 2% OC-10X, 2-Biphenyl-4-yl-2,3-dihydro-(1H)-quinazolin-4-one, Placebo Comparator, Placebo | OcuCure Therapeutics, Inc., Semler Research Center Pvt. Ltd. | Proliferative Diabetic Retinopathy (PDR) | 10/16 | 10/16 | | |
